Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

ConditionsChemotherapy Induced Peripheral Neuropathy (CIPN)Peripheral Neuropathy Due to Chemotherapy Peripheral Neuropathies Neuropathy

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorDana-Farber Cancer Institute

About this trial

This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).

Eligibility criteria

Qualifiers

Age 18 years old and older

Cancer survivors with no evidence of disease (cancer);

Completed neurotoxic chemotherapy, i.e., platinum agents, taxanes, vinca alkaloids, and bortezomib, at least three months before enrollment;

A CIPN diagnosis based on symptom history, loss of deep tendon reflexes, or presence of symmetrical stocking-glove pain, numbness, or paresthesia;

Disqualifiers

None

Trial design

Treatments tested in this trial

Tai Chi Program

Treatment groups

21 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

Source ClinicalTrials.gov